Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats
Sign Up to like & getrecommendations! Published in 2018 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-018-0831-3
Abstract: BackgroundAortic regurgitation (AR) is a valvular disease that can lead to systolic heart failure. Treatment options besides cardiac surgery are limited and consequently severe AR is associated with higher mortality and morbidity when not operated.… read more here.
Keywords: activator omecamtiv; omecamtiv mecarbil; myosin activator; cardiac myosin ... See more keywords